Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing.

Bi, Jianling; Newtson, Andreea M; Zhang, Yuping; Devor, Eric J; Samuelson, Megan I; Thiel, Kristina W; Leslie, Kimberly K

Bi, Jianling; Newtson, Andreea M; Zhang, Yuping; Devor, Eric J; Samuelson, Megan I; Thiel, Kristina W; Leslie, Kimberly K.

Afiliación

Bi J; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA.
Newtson AM; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA.
Zhang Y; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA.
Devor EJ; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA.
Samuelson MI; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA.
Thiel KW; Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.
Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA.

Cancers (Basel) ; 13(12)2021 Jun 10.

Article en En | MEDLINE | ID: mdl-34200645

Palabras clave

drug sensitivity testing; endometrial cancer; ovarian cancer; patient-derived organoids (PDOs); personalized medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google